Fedratinib
Inrebic
Near Add Your Location
Accepting patients
Decitabine Plus a JAK-Inhibitor
A Phase 2 Trial Investigating Decitabine in Combination With a JAK-Inhibitor as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant in Patients With Accelerated/Blast Phase Myeloproliferative Neoplasms
- Hypomethylating Agents (HMA)
- JAK1 Inhibitor
- JAK2 Inhibitor
- Phase 2